Skip to menu Skip to content Skip to footer
Dr Selwin Samuel
Dr

Selwin Samuel

Email: 
Phone: 
+61 7 344 34848

Overview

Background

Dr Selwin Samuel is a dental academic and early-career researcher with a diverse background spanning clinical dentistry, forensic odontology, immunology, and translational biomedical science. He completed his PhD at The University of Queensland, focusing on bone immunology and infectious complications in spinal cord injury, and currently serves as a Course Coordinator and Lecturer at the UQ School of Dentistry.

Availability

Dr Selwin Samuel is:
Not available for supervision

Qualifications

  • Doctor of Philosophy of Immunology, The University of Queensland

Research interests

  • Oral-Systemic Inflammation

    My research explores the link between oral inflammation and systemic immune responses, particularly in patients with chronic conditions

  • Forensic Odontology and Human Identification

    I contribute to research in human identification through dental records, bite mark analysis, and age estimation techniques

Research impacts

Selwin brings experience in multidisciplinary research, including a strong foundation in dentistry, which continues to inform his approach to teaching and research. His current interests lie at the intersection of oral health, systemic inflammation, and immune modulation. He is passionate about mentoring students, teaching, and designing clinically relevant, research-informed curricula.

Works

Search Professor Selwin Samuel’s works on UQ eSpace

6 works between 2022 and 2024

1 - 6 of 6 works

2024

Journal Article

A glucocorticoid spike derails muscle repair to heterotopic ossification after spinal cord injury

Alexander, Kylie A., Tseng, Hsu-Wen, Lao, Hong Wa, Girard, Dorothée, Barbier, Valérie, Ungerer, Jacobus P. J., McWhinney, Brett C., Samuel, Selwin G., Fleming, Whitney, Winkler, Ingrid G., Salga, Marjorie, Genêt, François, Banzet, Sébastien, Ruitenberg, Marc J. and Lévesque, Jean-Pierre (2024). A glucocorticoid spike derails muscle repair to heterotopic ossification after spinal cord injury. Cell Reports Medicine, 5 (12) 101849, 101849. doi: 10.1016/j.xcrm.2024.101849

A glucocorticoid spike derails muscle repair to heterotopic ossification after spinal cord injury

2024

Conference Publication

Endogenous glucocorticoids promote neurogenic heterotopic ossification after spinal cord injury and glucocorticoid receptor antagonist treatment prevents their development

Alexander, Kylie, Tseng, Hsu-Wen, Girard, Dorothee, Barbier, Valerie, Lao, Hong Wa, Samuel, Selwin G., Ungerer, Jacobus P. J., McWhinney, Brett C., Fleming, Whitney, Salga, Marjorie, Genet, Francois, Ruitenberg, Mark J., Banzet, Sebastien and Levesque, Jean-Pierre (2024). Endogenous glucocorticoids promote neurogenic heterotopic ossification after spinal cord injury and glucocorticoid receptor antagonist treatment prevents their development. 2024 Annual Meeting of the American Society for Bone and Mineral Research (ASBMR), Toronto, ON, Canada, 27-30 September 2024. Cary, NC, United States: Oxford University Press. doi: 10.1093/jbmr/zjae183

Endogenous glucocorticoids promote neurogenic heterotopic ossification after spinal cord injury and glucocorticoid receptor antagonist treatment prevents their development

2024

Journal Article

Interleukin-6 does not contribute to neurogenic heterotopic ossification pathogenesis

Girard, Dorothee, Tseng, Hsu-Wen, Rival, Bastien, Barbier, Valerie, Shatunova, Svetlana, Goriot, Marie-Emmanuelle, Samuel, Selwin Gabriel, Genet, Francois, Salga, Marjorie, Banzet, Sebastien, Alexander, Kylie A. and Levesque, Jean-Pierre (2024). Interleukin-6 does not contribute to neurogenic heterotopic ossification pathogenesis. Neurotrauma Reports, 5 (1), 1101-1112. doi: 10.1089/neur.2024.0106

Interleukin-6 does not contribute to neurogenic heterotopic ossification pathogenesis

2024

Journal Article

Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells

Shah, Esha T., Molloy, Christopher, Gough, Madeline, Kryza, Thomas, Samuel, Selwin G., Tucker, Amos, Bhatia, Maneet, Ferguson, Genevieve, Heyman, Rebecca, Vora, Shivam, Monkman, James, Bolderson, Emma, Kulasinghe, Arutha, He, Yaowu, Gabrielli, Brian, Hooper, John D., Richard, Derek J., O’Byrne, Kenneth J. and Adams, Mark N. (2024). Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells. British Journal of Cancer, 130 (7), 1196-1205. doi: 10.1038/s41416-024-02584-z

Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells

2023

Journal Article

Bacterial Lipopolysaccharides Exacerbate Neurogenic Heterotopic Ossification Development

Salga, Marjorie, Samuel, Selwin G., Tseng, Hsu‐Wen, Gatin, Laure, Girard, Dorothée, Rival, Bastien, Barbier, Valerie, Bisht, Kavita, Shatunova, Svetlana, Debaud, Charlotte, Winkler, Ingrid G., Paquereau, Julie, Dinh, Aurélien, Genêt, Guillaume, Kerever, Sébastien, Abback, Paer‐Sélim, Banzet, Sébastien, Genêt, François, Lévesque, Jean‐Pierre and Alexander, Kylie A. (2023). Bacterial Lipopolysaccharides Exacerbate Neurogenic Heterotopic Ossification Development. Journal of Bone and Mineral Research, 38 (11), 1-18. doi: 10.1002/jbmr.4905

Bacterial Lipopolysaccharides Exacerbate Neurogenic Heterotopic Ossification Development

2022

Journal Article

Inflammasomes and the IL-1 family in bone homeostasis and disease

Tseng, Hsu-Wen, Samuel, Selwin Gabriel, Schroder, Kate, Lévesque, Jean-Pierre and Alexander, Kylie A (2022). Inflammasomes and the IL-1 family in bone homeostasis and disease. Current Osteoporosis Reports, 20 (3), 170-185. doi: 10.1007/s11914-022-00729-8

Inflammasomes and the IL-1 family in bone homeostasis and disease

Media

Enquiries

For media enquiries about Dr Selwin Samuel's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au